Vizorifa 200 Tablet is an antibiotic medicine used to treat infectious diarrhea. It works by killing and stopping the growth of harmful bacteria in the intestines. This way it helps to get rid of the bad bacteria causing the infection, which in turn reduces the diarrhea.

It is an antibiotic.

Uses of Vizorifa Tablet

Treatment of Infectious diarrhea

Benefits of Vizorifa Tablet

In Treatment of Infectious diarrhea

Infectious diarrhea is a condition characterized by the sudden onset of loose or watery stools caused by harmful microorganisms in the digestive system. Vizorifa 200 Tablet helps treat infectious diarrhea by targeting and stopping the growth of harmful bacteria in the intestines. This medicine interferes with the bacteria's ability to make important proteins they need to survive and multiply. This helps to get rid of the bad bacteria causing the infection, which in turn reduces the diarrhea and helps you feel better.

Side effects of Vizorifa Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Vizorifa

Headache
Nausea
Fever
Abdominal pain
Vomiting
Flatulence
Constipation
Tenesmus (increased urge to pass stools)

How to use Vizorifa Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vizorifa 200 Tablet may be taken with or without food, but it is better to take it at a fixed time.

How Vizorifa Tablet works

Vizorifa 200 Tablet is an antibiotic. Vizorifa 200 Tablet inhibits the bacteria's ability to make proteins and stops the growth of bacteria that cause infectious diarrhea.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Vizorifa 200 Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Vizorifa 200 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

SAFE IF PRESCRIBED

Vizorifa 200 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving

SAFE

Vizorifa 200 Tablet does not usually affect your ability to drive.

Kidney

SAFE IF PRESCRIBED

Vizorifa 200 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Vizorifa 200 Tablet may not be needed in these patients. Please consult your doctor.

Liver

CAUTION

Vizorifa 200 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Vizorifa 200 Tablet may be needed. Please consult your doctor.

What if you forget to take Vizorifa Tablet?

If you miss a dose of Vizorifa 200 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Vizorifa 200 Tablet

₹24.9/Tablet

Rexigut 200mg Tablet

Leeford Healthcare Ltd

₹17.5/tablet

30% cheaper

Rafle 200 Tablet

Alembic Pharmaceuticals Ltd

₹19.64/tablet

21% cheaper

Rifagut Tablet

Sun Pharmaceutical Industries Ltd

₹17.1/tablet

31% cheaper

Rifastop 200 Tablet

Mankind Pharma Ltd

₹16.5/tablet

34% cheaper

Rcifax Tablet

Lupin Ltd

₹21.94/tablet

12% cheaper

View all substitutes

Quick tips

You have been prescribed Vizorifa 200 Tablet for the treatment of infectious diarrhea.
It should only be taken for a maximum of three days. If your symptoms do not improve after three days, inform your doctor. Do not take a second course of Vizorifa 200 Tablet.
It may cause reddish discoloration of urine. This is normal and harmless.
Stop taking Vizorifa 200 Tablet and inform your doctor if your diarrhoea gets worse or starts to contain blood or mucus.
Finish the full course of the medication, even if you feel better. Stopping the course early increases the risk of coming back of the infection.

Fact Box

Chemical Class

Rifamycin derivatives

Habit Forming

Therapeutic Class

GASTRO INTESTINAL

Action Class

RNA polymerase inhibitors- Rifamycins

Patient concerns

Diarrhea and dysentery last 15 days I had taken levofoxcin+ornidazol bd for 5 days along refaximin 400 tab bd for 5 day but it is start again

Dr. Sfurti Mann

Diabetology

Get a colonoscopy done for chronic Diarrhea

Is ethambutol salt is mendatory to treat tuberculosis. Is macox zh kid is complete composition of salt to treat tuberculosis.

Dr. Gopal Samdani

Paediatrics

Please consult infectious disease expert

FAQs

For how long should you take Vizorifa 200 Tablet?

The duration for which you may need to take Vizorifa 200 Tablet will depend upon the disease being treated. If it is prescribed for treatment of traveler's diarrhea, it is usually given for 3 days. When given for irritable bowel syndrome, it is usually given for 14 days.

Can Vizorifa 200 Tablet cure IBS?

Taking Vizorifa 200 Tablet can help improve the symptoms and delay the recurrence of the disease. However, it is not sure whether it will cure the disease completely or not. It has been shown that Vizorifa 200 Tablet can help improve the symptoms such as diarrhea, abdominal pain and discomfort. Consult your doctor for exact details on the treatment of IBS.

How long does Vizorifa 200 Tablet take to work for IBS?

Vizorifa 200 Tablet usually starts acting within 24 to 48 hours. The symptoms like diarrhea improve gradually after you start taking this medication. Usually, taking Vizorifa 200 Tablet for 2 weeks relieves the symptoms of IBS. Moreover, it has also been seen that this 2-week course of Vizorifa 200 Tablet provides relief for up to 10 weeks even after stopping the medication.

Related lab tests

Culture Stool

Stool Examination R/M

Top Physicians

4.3 ★

4.1 ★

4.2 ★

4.1 ★

4.9 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1215-16.
Medscape. Rifaximin. [Accessed 01 Apr. 2019] (online) Available from:
Rifaximin. Raleigh, North Carolina: Salix Pharmaceuticals, Inc.; 2014. [Accessed 01 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). Rifaximin. [Accessed 01 Apr. 2019] (online) Available from:
Robertson KD, Nagalli S. Rifaximin. [Updated 2023 May 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [Accessed 05 Aug. 2023] (online) Available from:
Rifaximin [Package Insert]. Jammu, Jammu & Kashmir: Torrent Pharmaceuticals Ltd. [Accessed 05 Aug. 2023] (online) Available from:

Marketer details

Name: Ventus Pharmaceuticals Pvt Ltd

Address: #33, Indira Colony Road, Subhash Nagar, Manimajra, CHANDIGARH 160 101 India

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.